These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1803615)

  • 1. The role of von Willebrand factor in pre-eclampsia.
    Bergmann F; Rotmensch S; Rosenzweig B; How H; Chediak J
    Thromb Haemost; 1991 Nov; 66(5):525-8. PubMed ID: 1803615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII: von Willebrand factor patterns in the plasma of patients with pre-eclampsia.
    Calvin S; Corrigan J; Weinstein L; Jeter M
    Am J Perinatol; 1988 Jan; 5(1):29-32. PubMed ID: 3122779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor multimer patterns in pregnancy-induced hypertension.
    Brenner B; Zwang E; Bronshtein M; Seligsohn U
    Thromb Haemost; 1989 Sep; 62(2):715-7. PubMed ID: 2510350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia.
    Thorp JM; White GC; Moake JL; Bowes WA
    Obstet Gynecol; 1990 Feb; 75(2):163-7. PubMed ID: 2300343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia.
    Deng L; Bremme K; Hansson LO; Blombäck M
    Obstet Gynecol; 1994 Dec; 84(6):941-5. PubMed ID: 7970473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma von Willebrand factor changes during various reproductive cycle stages in mixed-breed dogs with normal von Willebrand factor and in Doberman pinschers with type-I von Willebrand's disease.
    Moser J; Meyers KM; Russon RH; Reeves JJ
    Am J Vet Res; 1998 Jan; 59(1):111-8. PubMed ID: 9442254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
    Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is proteinuric pre-eclampsia a different disease in primigravida and multigravida?
    Barden AE; Beilin LJ; Ritchie J; Walters BN; Graham D; Michael CA
    Clin Sci (Lond); 1999 Oct; 97(4):475-83. PubMed ID: 10491348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
    Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
    Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
    Kumar RA; Moake JL; Nolasco L; Bergeron AL; Sun C; Dong JF; McIntire LV
    Biorheology; 2006; 43(5):681-91. PubMed ID: 17047284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in plasma von Willebrand factor and nitric oxide levels in patients with pregnancy induced hypertension].
    Jin LP; Wang CH; Chen JL
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):477-9. PubMed ID: 12536509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.
    Hulstein JJ; van Runnard Heimel PJ; Franx A; Lenting PJ; Bruinse HW; Silence K; de Groot PG; Fijnheer R
    J Thromb Haemost; 2006 Dec; 4(12):2569-75. PubMed ID: 16968329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.